New combo therapy may offer lasting hay fever relief
NCT ID NCT04502966
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether taking a grass pollen tablet (SLIT) together with the drug dupilumab for 2 years can help adults with moderate to severe hay fever tolerate grass pollen better, even after stopping treatment. About 199 participants were involved. The main goal was to see if this combination reduces nasal allergy symptoms during a pollen challenge one year after treatment ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINOCONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Brompton Hospital
London, SW36HP, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.